23518-25-4 ((Prosta-5,13-dien-1-oicacid, 9,11,15-trihydroxy-, (5Z,9a,11a,13E,15S)-(à)- (9CI))

Prosta-5,13-dien-1-oicacid, 9,11,15-trihydroxy-, (5Z,9a,11a,13E,15S)-(à)- (9CI);(5E,13E)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid;11-epi-PGE1;11-Epiprostaglandin E1;9-oxo-11S,15S-dihydroxy-13E-prostaenoic acid;AC1NR1IQ;Alprostadil impurity E [EP];Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11beta,13E,15S)-;Prostaglandin E(1);Prostaglandin F(2a);prostaglandin-E1;UNII-U0DO49Q8Y4;DINOPROST [HSDB];PGF-2alpha;9a,11a-PGF2;(+)-Prostaglandin F2a;HMS1361K16;NCGC00160385-04;cyclosin;Prostaglandin F2-alpha;Prostaglandin F2.alpha.;PDSP2_000079;Tox21_111777;Protamodin;SCHEMBL24292;B7IN85G1HY;7-(3, 5-dihydroxy-2-(3-hydroxyl-1-octenyl) cyclopentyl)-5-heptenoic acid;NCGC00160385-05;BML1-F08;(E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid;Prostaglandin F2a;U-14583;(5Z,13E,15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dien-1-oic acid;1ST11386;Dinoprostum;BDBM50035622;BRN 4153898;DB12789;A830494;amoglandin;CHEMBL815;Dinoprost [USAN:INN:BAN:JAN];Prostaglandin F2-alpha, racemic mixt.;PGF2alpha;Dinoprosta [INN-Spanish];Prostin F 2 alpha;5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, l-;prostaglandin F2alpha;5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (1R-(1alpha(Z),2beta(S*,E),3alpha,5alpha))-;Dinaprost;U 14583;15(R)-Prostaglandin F2 alpha;LMFA03010002;NCGC00160385-06;5-HEPTENOIC ACID, 7-(3,5-DIHYDROXY-2-(3-HYDROXY-1-OCTENYL)CYCLOPENTYL)-, dl-;(5z,9alpha,11alpha,13e,15s)-9,11,15-trihydroxyprosta-5,13-dienoic acid;PGF2;(E,Z)-(1R,2R,3R,5S)-7-[3,5-Dihydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]cyclopentyl]-5-heptenoic acid;9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid;dinoprost;Dinoprostum (INN-Latin);Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-;Enzaprost;Dinoprostum [INN-Latin];F2alpha, Prostaglandin;Prosmon (TN);PGF2.alpha.;(5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid;dl-Prostaglandin F2-alpha;15-epi PGF2alpha;(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-cyclopentyl)-hept-5-enoic acid;Prostaglandin-F2alpha;(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-3,13-dien-1-oic acid;U-14,583;HMS2089F11;CCG-208257;(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid;G02AD01;7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid;NCGC00160385-01;F2 alpha, Prostaglandin;Prostaglandin F2alpha, dl-;BSPBio_001494;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid;GTPL1884;P1885;HY-12956;Prostaglandin F2 alpha;(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoate;DINOPROST [USAN];CCRIS 4253;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(E)-(3S)-3-hydroxy-1-octenyl}-cyclopentyl]-5-heptenoic acid;PGF2a;9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid;AMY30098;C00639;Dinoprosta;Prostarmon F;PXGPLTODNUVGFL-YNNPMVKQSA-N;Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9-alpha,11-alpha,13E,15S)-(+-)-;(5Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxyoct-1-en-1-yl)cyclopentyl)hept-5-enoic acid;DINOPROST [JAN];5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, (+-)-;(5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate;UNII-B7IN85G1HY;NCGC00160385-02;(Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)cyclopentyl)hept-5-enoic acid;EX-A4115A;PGF2-alpha;CS-4232;HMS3648N11;IDI1_033964;Prostaglandin F(sub 2a);Prosmon;CHEBI:15553;l-Prostaglandin F2-alpha;DINOPROST [INN];9alpha,11alpha-PGF2;SR-01000946457;9alpha,11beta PGF2;Dinoprost; Prostaglandin F2a; PGF2alpha;BRN 2225571;HMS3402K16;DTXSID9022946;PGF2 alpha;Dinoprost (JP17/USAN/INN);Dinoprosta (INN-Spanish);9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid;SR-01000721847-2;panacelan;HSDB 3315;(+)-Prostaglandin F2alpha;SR-01000721847;PGF2alpha-[d4];(+-)-PGF2-alpha;(+-)-PGF2alpha;DINOPROST (MART.);Enzaprost F;HMS1791K16;alpha, PGF2;DINOPROST [WHO-DD];(z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-((s)-(e)-3-hydroxyoct-1-enyl)-cyclopentyl]hept-5-enoic acid;23518-25-4;NS00124545;DTXCID602946;7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid;PROSTAGLANDIN F2.ALPHA. [MI];D00081;CAS-551-11-1;l-PGF2-alpha;Prostin F2alpha;PGF2-alpha racemic mixt.;Q421375;551-11-1;SR-01000946457-1;HMS1989K16;SR-01000721847-4;13535-33-6;MFCD00135231;DINOPROST [MART.];AKOS030526160;EN300-21689745;Prosta-10,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S);Prostin F2-alpha;AS-56892;

PXGPLTODNUVGFL-YNNPMVKQSA-N

1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1

O[C@H]1C[C@H]([C@H](/C=C/[C@H](CCCCC)O)[C@H]1C/C=C\CCCC(=O)O)O